In Vitro & In Vivo Diagnostic Substances Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - In Vitro & In Vivo Diagnostic Substances
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2020-07-01
NTLAIntellia Therapeutics, Inc.Leonard John M.Pres, CEOS - Sale+OE$21.83-5,000525,767-1%-$109,150
D
2020-06-16
NTLAIntellia Therapeutics, Inc.Rivera Jose EEVP, GCS - Sale+OE$21.00-5,615284,492-2%-$117,915
2020-06-16
LNTHLantheus Holdings, Inc.Bolla John J.Chief Operations OfficerS - Sale$14.29-2,42260,419-4%-$34,603
2020-06-11
QDELQuidel Corp /de/Bryant Douglas CPres, CEOP - Purchase$160.33+5,000445,823+1%+$801,670
2020-06-11
CLDXCelldex Therapeutics, Inc.Young Diane C.SVP, Chief Medical OfficerP - Purchase$4.73+2,1152,115New+$10,004
2020-06-10
CLDXCelldex Therapeutics, Inc.Cavanaugh SarahSVP of Corp Affairs, Admin.P - Purchase$4.83+1,0501,367+331%+$5,072
2020-06-09
CLDXCelldex Therapeutics, Inc.Heath-Chiozzi MargoSVP of Regulatory AffairsP - Purchase$3.00+1,0001,000New+$3,005
2020-06-09
CLDXCelldex Therapeutics, Inc.Martin Samuel BatesSVP, CFOP - Purchase$3.05+9,75010,735+990%+$29,738
2020-06-09
CLDXCelldex Therapeutics, Inc.Marino James JDirP - Purchase$3.00+8,30512,704+189%+$24,915
2020-06-09
CLDXCelldex Therapeutics, Inc.Keler TiborEVP, CSOP - Purchase$2.99+5,0007,357+212%+$14,954
2020-06-09
CLDXCelldex Therapeutics, Inc.Marucci Anthony SPres, CEOP - Purchase$3.06+15,00019,438+338%+$45,900
D
2020-06-03
NTLAIntellia Therapeutics, Inc.Leonard John M.Pres, CEOS - Sale+OE$21.83-5,000525,767-1%-$109,150
M
2020-06-03
HSKAHeska CorpWilson Kevin S.CEO, PresS - Sale$90.01-19,707407,187-5%-$1,773,923
D
2020-05-29
IDXXIdexx Laboratories Inc /deTwigge GiovaniCORPORATE VPS - Sale+OE$307.73-14,07012,892-52%-$4,329,754
D
2020-05-28
QTNTQuotient LtdStackawitz JeremyChief Commercial OfficerS - Sale+OE$7.41-11,000142,926-7%-$81,510
D
2020-05-28
QTNTQuotient LtdFarrell EdwardCOOS - Sale+OE$7.40-12,81129,013-31%-$94,801
D
2020-05-26
NTLAIntellia Therapeutics, Inc.Rivera Jose EEVP, GCS - Sale+OE$21.21-5,615280,107-2%-$119,094
M
2020-05-26
HSKAHeska CorpWilson Kevin S.CEO, PresS - Sale$86.30-15,559426,894-4%-$1,342,687
D
2020-05-22
QDELQuidel Corp /de/Kroll WernerSVP, R, DS - Sale+OE$174.44-68,1526,671-91%-$11,888,149
2020-05-20
QDELQuidel Corp /de/Bujarski Robert JosephSVP, NA Comm Ops, GCS - Sale$189.41-20,00013,383-60%-$3,788,282
2020-05-22
VNRXVolitionrx LtdReynolds Cameron JohnPres, CEOP - Purchase$2.75+4,0002,168,0670%+$11,000
2020-05-20
OXFDOxford Immunotec Global PlcBalthrop Patrick JDirP - Purchase$12.48+4,0004,000New+$49,920
2020-05-19
HSKAHeska CorpWilson Kevin S.CEO, PresS - Sale$85.00-1,734442,4530%-$147,390
2020-05-18
QDELQuidel Corp /de/Steward Randall JCFOS - Sale$185.35-20,0002,848-88%-$3,707,040
D
2020-05-18
QDELQuidel Corp /de/Borkar Ratan SSVP, Intl Comm OperationsS - Sale+OE$192.82-28,312524-98%-$5,459,113
D
2020-05-18
QDELQuidel Corp /de/Abney Michael Donald Jr.SVP - DistributionS - Sale+OE$198.46-15,9706,634-71%-$3,169,387
2020-05-18
IDXXIdexx Laboratories Inc /deTurner Kathy VCorporate VPS - Sale$301.00-2,69010,212-21%-$809,690
D
2020-05-19
IDXXIdexx Laboratories Inc /deJunius Daniel MDirS - Sale+OE$295.61-4,0002,834-59%-$1,182,433
M
2020-05-18
IDXXIdexx Laboratories Inc /deAyers Jonathan WDirS - Sale$296.67-38,000820,467-4%-$11,273,470
D
2020-05-13
IDXXIdexx Laboratories Inc /deHenderson Rebecca MDirS - Sale+OE$286.66-13,39614,696-48%-$3,840,052
2020-05-11
QDELQuidel Corp /de/Buechler Kenneth FDirS - Sale$200.00-5,00055,882-8%-$1,000,000
M
2020-05-11
IDXXIdexx Laboratories Inc /deAyers Jonathan WDirS - Sale$295.17-50,000858,467-6%-$14,758,300
2020-05-11
QDELQuidel Corp /de/Polan Mary Lake Ph DDirS - Sale$204.27-6,70020,784-24%-$1,368,630
D
2020-05-11
IDXXIdexx Laboratories Inc /dePolewaczyk James FEVPS - Sale+OE$298.85-16,26417,772-48%-$4,860,515
D
2020-05-08
IDXXIdexx Laboratories Inc /deAyers Jonathan WDirS - Sale+OE$291.63-21,130908,467-2%-$6,162,059
M
2020-05-08
OXFDOxford Immunotec Global PlcWrighton-Smith PeterCEOP - Purchase$11.46+43,600400,225+12%+$499,475
DM
2020-05-04
IDXXIdexx Laboratories Inc /deAyers Jonathan WDirS - Sale+OE$281.07-39,600908,467-4%-$11,130,402
2020-05-05
NEOGNeogen CorpLilly Jason WarrenVPS - Sale$64.00-88510,409-8%-$56,640
2020-05-01
IMMUImmunomedics IncAvoro Capital Advisors LLCSee Remarks, 10%P - Purchase$28.50+1,750,00026,363,516+7%+$49,875,000
2020-04-28
LNTHLantheus Holdings, Inc.Duffy Michael PSVP, GCS - Sale$13.13-7,198133,402-5%-$94,529
2020-04-27
LNTHLantheus Holdings, Inc.Heino Mary AnnePres, CEOS - Sale$13.77-30,033634,318-5%-$413,407
2020-04-24
OCXOncocyte CorpBroadwood Partners, L.P.10%P - Purchase$2.27+1,050,00029,435,553+4%+$2,383,500
2020-04-21
NEOGNeogen CorpHerbert James LDirS - Sale$66.13-19,36822,476-46%-$1,280,835
2020-04-03
NEOGNeogen CorpHerbert James LDirS - Sale$63.16-20,00019,972-50%-$1,263,200
AM
2020-03-30
OCXOncocyte CorpAndrews Ronald AsburyCEO, PresP - Purchase$2.30+45,21662,698+259%+$104,150
EM
2020-03-30
OCXOncocyte CorpAndrews Ronald AsburyCEO, PresP - Purchase$1.41+45,21662,698+259%+$63,826
2020-03-25
NEOGNeogen CorpAdent John EdwardPres, CEOP - Purchase$58.24+1,75016,080+12%+$101,920
2020-01-08
NEOGNeogen CorpAdent John EdwardPres, CEOP - Purchase$65.40+1,51714,330+12%+$99,212
2020-03-26
NEOGNeogen CorpTobin James PDirP - Purchase$60.62+7345,500+15%+$44,495
2020-03-16
VIVOMeridian Bioscience IncWilliams FeliciaDirP - Purchase$6.02+1,5505,717+37%+$9,331
D
2020-03-13
QTNTQuotient LtdBuhler PeterCFOP - Purchase$4.04+10,00010,000New+$40,400
D
2020-03-13
QTNTQuotient LtdVon Prondzynski HeinoDirP - Purchase$4.00+30,000239,922+14%+$120,000
2020-03-12
VIVOMeridian Bioscience IncKenny John P.CEOP - Purchase$5.78+30,000238,324+14%+$173,541
2020-03-12
ICCCImmucell Corp /de/Cunningham DavidDirP - Purchase$4.00+2,00015,000+15%+$8,000
2020-03-11
ICCCImmucell Corp /de/Tomsche David ScottDirP - Purchase$4.28+4,60085,519+6%+$19,688
2020-03-10
VIVOMeridian Bioscience IncBaldasare Bryan TEVP, CFOP - Purchase$6.97+2,00052,637+4%+$13,936
2020-03-06
LNTHLantheus Holdings, Inc.Duffy Michael PSVP, GCS - Sale$14.58-1,936140,600-1%-$28,229
2020-03-05
LNTHLantheus Holdings, Inc.Heino Mary AnnePres, CEOS - Sale$15.35-9,019664,351-1%-$138,408
2020-02-28
AKERAkers Biosciences, Inc.Hudson Bay Capital Management LP10%S - Sale$2.81-638240,3050%-$1,793
M
2020-02-27
LNTHLantheus Holdings, Inc.Marshall Robert J. Jr.CFO, TreasurerS - Sale$15.66-2,43550,993-5%-$38,137
2020-02-27
LNTHLantheus Holdings, Inc.McHugh JulieDirS - Sale$15.86-1,75615,754-10%-$27,845
2020-02-27
LNTHLantheus Holdings, Inc.Bolla John J.Chief Operations OfficerS - Sale$15.79-1,25135,154-3%-$19,750
2020-02-27
LNTHLantheus Holdings, Inc.Leno Sam RDirS - Sale$15.85-2,70035,372-7%-$42,792
2020-02-27
LNTHLantheus Holdings, Inc.Robertson A FrederickDirS - Sale$15.86-2,66040,402-6%-$42,193
2020-02-27
LNTHLantheus Holdings, Inc.Duffy Michael PSVP, GCS - Sale$15.79-1,552116,493-1%-$24,501
2020-02-27
ICCCImmucell Corp /de/Tomsche David ScottDirP - Purchase$4.98+5,13080,919+7%+$25,547
D
2020-02-26
QDELQuidel Corp /de/Russell Edward KeithSVP, Business DevelopmentS - Sale+OE$79.58-12,60117,190-42%-$1,002,796
M
2020-02-26
LNTHLantheus Holdings, Inc.Heino Mary AnnePres, CEOS - Sale$16.27-31,615524,399-6%-$514,319
M
2020-02-25
AKERAkers Biosciences, Inc.Hudson Bay Capital Management LP10%S - Sale$2.81-28,300497,186-5%-$79,576
A
2020-02-18
NEOGNeogen CorpHerbert James LDirS - Sale$72.04-14,61489,456-14%-$1,052,863
2020-02-24
LNTHLantheus Holdings, Inc.Heino Mary AnnePres, CEOS - Sale$16.06-9,898556,014-2%-$158,970
2020-02-25
VIVOMeridian Bioscience IncMcIlwraith JohnDirP - Purchase$7.59+5,00017,167+41%+$37,950
2020-02-24
VIVOMeridian Bioscience IncRice John McCune Jr.DirP - Purchase$7.52+3,00012,167+33%+$22,547
DM
2020-02-20
IDXXIdexx Laboratories Inc /deAyers Jonathan WDirS - Sale+OE$284.92-23,400946,811-2%-$6,667,109
A
2020-02-19
IDXXIdexx Laboratories Inc /deAyers Jonathan WDirS - Sale$293.62-39,143947,861-4%-$11,493,155
2020-02-21
VIVOMeridian Bioscience IncKenny John P.CEOP - Purchase$7.65+10,000208,324+5%+$76,546
2020-02-19
IDXXIdexx Laboratories Inc /deAyers Jonathan WDirS - Sale$293.62-39,143948,361-4%-$11,493,155
D
2020-02-18
IDXXIdexx Laboratories Inc /deVandebroek Sophie V.DirS - Sale+OE$286.89-7,5689,321-45%-$2,171,202
2020-02-18
IDXXIdexx Laboratories Inc /deAyers Jonathan WDirS - Sale$286.84-40,000987,004-4%-$11,473,578
2020-02-20
NAVBNavidea Biopharmaceuticals, Inc.Latkin JedCEO, COO, CFOP - Purchase$1.08+5,00017,950+39%+$5,400
2020-02-13
NAVBNavidea Biopharmaceuticals, Inc.Scott John K Jr.10%P - Purchase$0.85+2,373,5298,052,301+42%+$2,017,500
2020-02-18
NEOGNeogen CorpHerbert James LDirS - Sale$72.04-89,45689,456-50%-$6,444,840
D
2020-02-14
NEOGNeogen CorpLilly Jason WarrenVPS - Sale+OE$72.75-7,10711,294-39%-$517,040
2020-02-10
NEOGNeogen CorpHerbert James LDirS - Sale$69.72-30,000126,570-19%-$2,091,543
2020-02-12
MYGNMyriad Genetics IncLambert NicolePres, MGLS - Sale$19.73-4,35459,150-7%-$85,915
DM
2020-02-11
NEOGNeogen CorpQuinlan Steven J.VP, CFOS - Sale+OE$72.02-13,00213,470-49%-$936,370
D
2020-02-10
NEOGNeogen CorpLilly Jason WarrenVPS - Sale+OE$70.01-7,12010,401-41%-$498,471
D
2020-02-05
IDXXIdexx Laboratories Inc /deMazelsky Jonathan JayPres, CEOS - Sale+OE$277.84-8,00042,685-16%-$2,222,692
DM
2020-02-05
NEOGNeogen CorpLilly Jason WarrenVPS - Sale+OE$70.02-5,36410,401-34%-$375,573
2020-02-05
MYGNMyriad Genetics IncFord AlexanderPres, MWHS - Sale$30.00-7,273142,438-5%-$218,190
2020-02-03
NEOGNeogen CorpHerbert James LDirS - Sale$68.33-30,000156,970-16%-$2,049,787
D
2020-01-16
NEOGNeogen CorpBoehm William TDirS - Sale+OE$70.00-2,00010,479-16%-$140,000
DM
2020-01-08
NEOGNeogen CorpReed Thomas HDirS - Sale+OE$65.66-7,6678,010-49%-$503,407
D
2020-01-16
NEOGNeogen CorpMorrical Terri AVPS - Sale+OE$69.77-39,46737,575-51%-$2,753,688
D
2020-01-14
NEOGNeogen CorpQuinlan Steven J.VP, CFOS - Sale+OE$69.65-8,03113,470-37%-$559,376
M
2020-01-09
NEOGNeogen CorpHerbert James LDirS - Sale$65.32-17,33939,972-30%-$1,132,537
M
2019-12-09
AKERAkers Biosciences, Inc.Hudson Bay Capital Management LP10%P - Purchase$3.01+184,578373,261+98%+$555,550
2020-01-02
OCXOncocyte CorpBroadwood Partners, L.P.10%P - Purchase$2.16+1,391,46627,335,553+5%+$3,000,001
2020-01-06
NEOGNeogen CorpHerbert James LDirS - Sale$64.61-20,00057,311-26%-$1,292,118
2019-12-27
NEOGNeogen CorpHerbert James LDirS - Sale$64.56-20,00077,311-21%-$1,291,266
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top